159 related articles for article (PubMed ID: 10166232)
21. [Interventions by clinical pharmacists on surgical wards - impact on antibiotic therapy].
Weber A; Schneider C; Grill E; Strobl R; Vetter-Kerkhoff C; Jauch KW
Zentralbl Chir; 2011 Feb; 136(1):66-73. PubMed ID: 21337293
[TBL] [Abstract][Full Text] [Related]
22. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.
Kollef MH
Clin Infect Dis; 2000 Sep; 31 Suppl 4():S131-8. PubMed ID: 11017862
[TBL] [Abstract][Full Text] [Related]
23. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
[TBL] [Abstract][Full Text] [Related]
24. Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy.
Vogtländer NP; Van Kasteren ME; Natsch S; Kullberg BJ; Hekster YA; Van Der Meer JW
Arch Intern Med; 2004 Jun; 164(11):1206-12. PubMed ID: 15197046
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
Marras TK; Nopmaneejumruslers C; Chan CK
Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
[TBL] [Abstract][Full Text] [Related]
26. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
[TBL] [Abstract][Full Text] [Related]
27. [Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy].
Fernández P; San Martín L
Rev Med Chil; 2000 Mar; 128(3):267-72. PubMed ID: 10962867
[TBL] [Abstract][Full Text] [Related]
28. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
[TBL] [Abstract][Full Text] [Related]
29. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Joseph J; Rodvold KA
Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
[TBL] [Abstract][Full Text] [Related]
30. [National multicenter survey: the use of intravenous antimicrobial agents].
Gutiérrez Zufiaurre MN; García-Rodríguez JA
Rev Esp Quimioter; 2006 Dec; 19(4):349-56. PubMed ID: 17235404
[TBL] [Abstract][Full Text] [Related]
31. How short can courses be in lower respiratory tract infections?
Siegel R
J Int Med Res; 2000; 28 Suppl 1():37A-47A. PubMed ID: 11092228
[TBL] [Abstract][Full Text] [Related]
32. Switch therapy in community-acquired pneumonia.
Ramirez JA
Diagn Microbiol Infect Dis; 1995; 22(1-2):219-23. PubMed ID: 7587043
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia].
Cousson J; Floch T; Vernet-Garnier V; Appriou M; Petit JS; Jovenin N; Lamiable D; Hoizey G
Pathol Biol (Paris); 2005; 53(8-9):546-50. PubMed ID: 16023303
[TBL] [Abstract][Full Text] [Related]
34. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey.
Astagneau P; Fleury L; Leroy S; Lucet JC; Golliot F; Régnier B; Brücker G
J Hosp Infect; 1999 Aug; 42(4):303-12. PubMed ID: 10467544
[TBL] [Abstract][Full Text] [Related]
35. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
36. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.
Lancaster JW; Lawrence KR; Fong JJ; Doron SI; Garpestad E; Nasraway SA; Devlin JW
Pharmacotherapy; 2008 Jul; 28(7):852-62. PubMed ID: 18576900
[TBL] [Abstract][Full Text] [Related]
37. Transitional (intravenous to oral) antibiotic therapy.
Quintiliani R; Grant E; Quintiliani R
J Med Liban; 2000; 48(4):233-40. PubMed ID: 11214195
[TBL] [Abstract][Full Text] [Related]
38. Oral antibiotic treatment of MRSA infections.
Cunha BA
J Hosp Infect; 2005 May; 60(1):88-90. PubMed ID: 15823667
[No Abstract] [Full Text] [Related]
39. Oral antibiotic therapy of serious systemic infections.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1197-222. PubMed ID: 17116444
[TBL] [Abstract][Full Text] [Related]
40. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century.
Paskovaty A; Pflomm JM; Myke N; Seo SK
Int J Antimicrob Agents; 2005 Jan; 25(1):1-10. PubMed ID: 15620820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
